| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $1,336.71 | $41,999.58 | $62,999.37 | |
CareSource
| Professional | $742.61 | $1,098.01 | $1,470.37 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab, includes infusion or injection, and post administration monitoring in the home or residence. This includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $1,336.71 | $41,999.58 | $62,999.37 | |
CareSource
| Professional | $742.61 | $1,098.01 | $1,470.37 |